Related Experiment Video
Updated: Sep 10, 2025

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
Association between Chinese visceral adiposity index and heart failure in diabetic patients
Shiwei Kang1, Shuohua Chen2, Zuxu Lin1
1School of Public Health, North China University of Science and Technology, Tangshan, China.
Insights
The Chinese visceral adiposity index (CVAI) is linked to a higher risk of heart failure (HF) in diabetic patients. This index is particularly useful for identifying increased HF risk in elderly individuals.
Area of Science:
- Cardiology
- Endocrinology
- Public Health
Background:
- Diabetes mellitus is a significant risk factor for cardiovascular diseases, including heart failure (HF).
- Visceral adiposity plays a crucial role in the pathogenesis of cardiovascular complications in diabetic individuals.
- Accurate risk stratification for HF in diabetic populations is essential for effective prevention and management.
Purpose of the Study:
- To investigate the association between the Chinese visceral adiposity index (CVAI) and the risk of developing heart failure (HF) in patients with diabetes.
- To compare the predictive capability of CVAI against other established obesity metrics for HF risk.
Main Methods:
- A prospective cohort study (Kailuan Study) included 12,243 diabetic patients followed from 2006 to 2022.
- Participants were categorized into quartiles based on their CVAI values.
- Kaplan-Meier analysis, Cox regression, and ROC analysis were employed to assess the relationship between CVAI and HF incidence and its predictive accuracy.
Main Results:
- Over a median of 15 years, 861 new HF cases were identified.
- HF incidence demonstrated a significant increasing trend across higher CVAI quartiles (p < 0.05).
- Higher CVAI levels were independently associated with increased HF risk, with a notable interaction observed in patients aged 60 years and older.
Conclusions:
- The Chinese visceral adiposity index (CVAI) is an independent predictor of heart failure risk in diabetic individuals.
- CVAI demonstrates superior predictive accuracy compared to other obesity indices for HF.
- CVAI is particularly valuable for risk stratification of visceral fat-related HF, especially in elderly diabetic patients.
Aims:
This study aimed to investigate the association between Chinese visceral adiposity index (CVAI) and heart failure (HF) risk in diabetic individuals and to evaluate the predictive capability of CVAI compared to other obesity metrics.
Materials And Methods:
A prospective cohort study (Kailuan Study) spanning 2006 to 2022 involved 12 243 diabetic patients. Participants were stratified into CVAI quartiles (Q1: <96.13, n = 3060; Q2: 96.13 to <121.25, n = 3061; Q3: 121.25 to <146.85, n = 3061; Q4: ≥146.85, n = 3061). The relationship between CVAI and HF occurrence was assessed using the Kaplan-Meier analysis and Cox regression models, supplemented by sensitivity analyses. Restricted cubic splines were used to evaluate potential nonlinear associations. Subgroup analyses examined the influence of sociodemographic factors and health behaviours. Receiver operating characteristic (ROC) analysis compared CVAI with other obesity indices. Statistical significance was set at p < 0.05.
Results:
Over a median follow-up of 15 years, 861 new HF cases were recorded. HF incidence rose with increasing CVAI quartiles (Q1-Q4: 3.05-7.20/1000 person-years; p < 0.05). Adjusted HRs (95% CI) for HF in Q2-Q4 compared to Q1 were 1.32 (1.06-1.65), 1.41 (1.13-1.75) and 1.91 (1.55-2.35) (Ptrend < 0.01). Age significantly modified the CVAI-HF relationship (≥60 years: HR = 2.06, 1.60-2.64; Pinteraction <0.01). CVAI exhibited a linear correlation with HF (Pnonlinear = 0.75) and demonstrated superior ROC-predictive accuracy compared to other indices (p < 0.01).
Conclusion:
CVAI is independently associated with HF risk, especially in elderly patients, supporting its utility for visceral fat-related risk stratification.
Related Concept Videos
Heart Failure III: Clinical Manifestations
Heart Failure I: Introduction
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure II: Pathophysiology
Cholesterol: Significance and Regulation
Considering cholesterol and...
Coronary Artery Disease I: Introduction

